Meghan Davis, an autologous stem cell transplant recipient, shares her journey living with diffuse cutaneous systemic sclerosis and her decision to receive stem cell therapy treatment. Talaris Therapeutics Senior Scientific Advisor, Dr. Suzanne Ildstad, and Chief Medical Officer, Dr. Nancy Krieger, discuss the challenges and high unmet medical needs in this community while reviewing Talaris Therapeutics’ investigational cell therapy in FREEDOM-3, a Phase 2 clinical trial being conducted in patients suffering from diffuse cutaneous systemic sclerosis.
#scleroderma #autoimmunedisease #dcSSc #systemicsclerosis
7 июл 2022
